Rheumatoid arthritis increases the risk of coronary heart disease via vascular endothelial injuries

Medical Hypotheses

Volumn 63, Issue 3, 2004, Pages 442-445

  Wang, Lexin ^a,b   Feng, Guoqin ^b  

^a CHARLES STURT UNIVERSITY   (Australia)

^b WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOTHELIUM INJURY; HUMAN; INCIDENCE; INFLAMMATION; MORTALITY; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT;

EID: 3342981486     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2003.11.040     Document Type: Article

References (29)

1. Prior O., Symmons D., Scott D., et al. Cause of death in rheumatoid arthritis. Br J. Rheumatol. 23:1984;92-99
2. Jacobsson L.T.H., Knowler W.C., Pillemer S., et al. Rheumatoid arthritis and mortality - a longitudinal study in Pima Indians. Arthritis Rheum. 36:1993;1045-1053
3. Wolfe F., Freundlich B., Straus W.L. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J. Rheumatol. 30:2003;36-40
4. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003 [in press]
5. Mikuls T.R., Saag K.G., Criswell L.A., et al. Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study. Ann. Rheum. Dis. 61:2002;994-999
6. Bacon P.A., Kitas G.D. The significance of vascular inflammation in rheumatoid arthritis. Ann. Rheum. Dis. 53:1994;621-623
7. Ross R. Mechanisms of disease: atherosclerosis, an inflammatory disease. N. Engl. J. Med. 340:1999;115-126
8. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115
9. Jonsson S.W., Backman C., Johnson O., et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J. Rheumatol. 28:2001;2597-2602
10. Goodson N. Coronary artery disease and rheumatoid arthritis. Cur. Opin. Rheumatol. 14:2002;115-120
11. del Rincon I., Williams K., Stern M.P., Freeman G.L., Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 44:2001;2737-2745
12. Bergholm R., Leirisalo-Repo M., Vehkavaara S., Mäkimattila S., Taskinen M.R., Yki-Järvinen H. Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler. Thromb. Vasc. Biol. 22:2002;1637-1641
13. Raza K., Thambyrajah J., Townend J.N., et al. Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation. 102(26):2000;1470-1472
14. Wang P., Ba Z., Caudry I. Administration of tumor necrosis factor alpha in vivo depresses endothelium-dependent relaxation. Am. J. Physiol. 266:1994;H2535-H2541
15. Savage C.O.S., Pottinger B.E., Gaskin G., et al. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am. J. Pathol. 141:1992;335-342
16. Morel D.W., Hessler J.R., Chisolm G.M. Low-density lipoprotein cytotoxicity induced by free-radical peroxidation of lipid. J. Lipid Res. 24:1983;1070-1076
17. Wallberg-Jonsson S., Cvetkovic J.T., Sundqvist K.G., Lefvert A.K., Rantapaa-Dahlqvst S. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J. Rheumatol. 29:2002;875-882
18. Aengevaeren W.R. Beyond lipids - the role of the endothelium in coronary artery disease. Atherosclerosis. 147(Suppl 1):1999;S11-S16
19. Iiyyama K., Nagano M., Yo T., et al. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am. Heart J. 132:1996;779-782
20. Perticone F., Ceravolo R., Pujia A., et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 104:2001;191-196
21. Sorensen K.E., Celermajer D.S., Georgakopoulos D., Hatcher G., Betteridge D.J., Deanfield J.E. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to lipoprotein (a) level. J. Clin. Invest. 93:1994;50-55
22. Celermajor D.S., Sorensen K.E., Georgakopoulos D., et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 88:1993;2149-2155
23. Ghiadoni L., Donald A.E., Cropley M., et al. Mental stress induces transient endothelial dysfunction in humans. Circulation. 102:2000;2473-2478
24. Ross R. Atheroclerosis: an inflammatory disease. N. Engl. J. Med. 340:1999;115-126
25. Alexander R.W. Hypertension and the pathogenesis of atherosclerotic oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension. 25:1995;155-161
26. Bhagat K., Vallance P. Inflammatory cytokines impair endothelium- dependent dilation in human veins in vivo. Circulation. 96:1997;3042-3047
27. Fichtlscherer S., Rosenberger G., Walter D.H., Breuer S., Dimmeler S., Zeiher A.M. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation. 102:2000;1000-1006
28. Sinisalo J., Paronen J., Mattila K.J., et al. Relation of inflammation to vascular function in patients with coronary heart disease. Atherosclerosis. 149:2000;403-411
29. Cleland S.J., Sattar N., Petrie J.R., Forouhi N.G., Elliott H.L., Connell J.M.C. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin. Sci. 98:2000;531-535